BTC Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.1M | Buy |
75,841
+1,524
| +2% | +$328K | 1.16% | 21 |
|
|
2026
Q1 | $16.2M | Buy |
74,317
+2,401
| +3% | +$533K | 1.09% | 23 |
|
|
2025
Q4 | $16.4M | Sell |
71,916
-790
| -1% | -$180K | 1.15% | 24 |
|
|
2025
Q3 | $16.8M | Buy |
72,706
+3,706
| +5% | +$755K | 1.16% | 25 |
|
|
2025
Q2 | $12.7M | Buy |
69,000
+6,918
| +11% | +$1.29M | 1.04% | 25 |
|
|
2025
Q1 | $13M | Sell |
62,082
-2,676
| -4% | -$520K | 1.19% | 24 |
|
|
2024
Q4 | $11.5M | Sell |
64,758
-2,446
| -4% | -$450K | 1.07% | 26 |
|
|
2024
Q3 | $13.3M | Sell |
67,204
-3,864
| -5% | -$721K | 1.18% | 21 |
|
|
2024
Q2 | $12.2M | Sell |
71,068
-25
| -0% | -$4.14K | 1.13% | 24 |
|
|
2024
Q1 | $12.9M | Buy |
+71,093
| New | +$12.3M | 1.18% | 20 |
|
|
2023
Q3 | $11.2M | Buy |
75,023
+1,085
| +1% | +$159K | 1.29% | 18 |
|
|
2023
Q2 | $9.96M | Sell |
73,938
-809
| -1% | -$119K | 1.08% | 23 |
|
|
2023
Q1 | $11.9M | Buy |
74,747
+279
| +0.4% | +$42.7K | 1.36% | 16 |
|
|
2022
Q4 | $12M | Buy |
74,468
+31,825
| +75% | +$4.88M | 1.45% | 17 |
|
|
2022
Q3 | $5.72M | Buy |
42,643
+6,314
| +17% | +$906K | 0.75% | 43 |
|
|
2022
Q2 | $5.56M | Sell |
36,329
-1,821
| -5% | -$278K | 0.68% | 46 |
|
|
2022
Q1 | $6.2M | Sell |
38,150
-11,426
| -23% | -$1.66M | 0.61% | 57 |
|
|
2021
Q4 | $6.71M | Buy |
49,576
+2,404
| +5% | +$284K | 0.66% | 48 |
|
|
2021
Q3 | $5.09M | Sell |
47,172
-2,621
| -5% | -$299K | 0.57% | 56 |
|
|
2021
Q2 | $5.63M | Sell |
49,793
-196
| -0.4% | -$22.1K | 0.64% | 52 |
|
|
2021
Q1 | $5.41M | Buy |
49,989
+4,126
| +9% | +$441K | 0.6% | 55 |
|
|
2020
Q4 | $4.92M | Buy |
45,863
+12,319
| +37% | +$1.18M | 0.59% | 60 |
|
|
2020
Q3 | $2.93M | Sell |
33,544
-868
| -3% | -$81.7K | 0.41% | 76 |
|
|
2020
Q2 | $3.38M | Sell |
34,412
-2,042
| -6% | -$180K | 0.52% | 66 |
|
|
2020
Q1 | $2.78M | Sell |
36,454
-2,763
| -7% | -$235K | 0.53% | 66 |
|
|
2019
Q4 | $3.48M | Sell |
39,217
-291
| -0.7% | -$24.2K | 0.5% | 75 |
|
|
2019
Q3 | $2.99M | Sell |
39,508
-1,459
| -4% | -$100K | 0.48% | 75 |
|
|
2019
Q2 | $2.98M | Sell |
40,967
-12,654
| -24% | -$995K | 0.48% | 78 |
|
|
2019
Q1 | $4.32M | Buy |
53,621
+3,899
| +8% | +$319K | 0.69% | 49 |
|
|
2018
Q4 | $4.58M | Buy |
49,722
+648
| +1% | +$57K | 0.82% | 35 |
|
|
2018
Q3 | $4.64M | Sell |
49,074
-10,302
| -17% | -$977K | 0.79% | 41 |
|
|
2018
Q2 | $5.5M | Buy |
59,376
+5,435
| +10% | +$531K | 1.3% | 24 |
|
|
2018
Q1 | $5.1M | Sell |
53,941
-7,014
| -12% | -$770K | 0.83% | 37 |
|
|
2017
Q4 | $5.89M | Buy |
60,955
+1,137
| +2% | +$107K | 1.01% | 27 |
|
|
2017
Q3 | $5.32M | Buy |
59,818
+8,410
| +16% | +$640K | 0.95% | 28 |
|
|
2017
Q2 | $3.73M | Sell |
51,408
-244
| -0.5% | -$16.4K | 0.67% | 51 |
|
|
2017
Q1 | $3.37M | Sell |
51,652
-1,640
| -3% | -$103K | 0.63% | 58 |
|
|
2016
Q4 | $3.33M | Buy |
53,292
+8,006
| +18% | +$489K | 0.66% | 60 |
|
|
2016
Q3 | $2.86M | Buy |
45,286
+10,927
| +32% | +$707K | 0.6% | 65 |
|
|
2016
Q2 | $2.13M | Buy |
34,359
+1,022
| +3% | +$62.3K | 0.46% | 83 |
|
|
2016
Q1 | $1.91M | Buy |
33,337
+1,595
| +5% | +$88.9K | 0.44% | 88 |
|
|
2015
Q4 | $1.88M | Buy |
31,742
+1,243
| +4% | +$71.6K | 0.44% | 90 |
|
|
2015
Q3 | $1.66M | Buy |
30,499
+1,937
| +7% | +$126K | 0.4% | 98 |
|
|
2015
Q2 | $1.92M | Sell |
28,562
-12,321
| -30% | -$804K | 0.45% | 95 |
|
|
2015
Q1 | $2.39M | Sell |
40,883
-8,862
| -18% | -$535K | 0.55% | 77 |
|
|
2014
Q4 | $3.26M | Buy |
49,745
+195
| +0.4% | +$12.3K | 0.81% | 38 |
|
|
2014
Q3 | $2.87M | Buy |
+49,550
| New | +$2.75M | 0.73% | 52 |
|
Other funds holding ABBV
ECSS
ATO
BTC Capital Management's ABBV Position: Q2 2026 in Review
BTC Capital Management increased its AbbVie (ABBV) stake by 2.1% in Q2 2026, buying an estimated $328K and bringing the position to 75,841 shares worth $19.1M. The position accounts for 1.16% of the portfolio, ranked #21.
BTC Capital Management first reported a position in ABBV in Q3 2014 and has held it in 47 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- BTC Capital Management held 75,841 shares of AbbVie worth $19.1M as of Q2 2026.
- BTC Capital Management bought 1,524 AbbVie shares in Q2 2026, an estimated $328K.
- AbbVie made up 1.16% of BTC Capital Management's portfolio in Q2 2026, its #21 holding.
- BTC Capital Management first reported a position in AbbVie in Q3 2014 and has held it in 47 quarters since.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on BTC Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.